Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery of Prostate Cancer.
Sumith A KularatneMini ThomasCarrie H MyersPravin GagareAnanda Kumar KanduluruChrista J CrianBrandy N CichockiPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2018)
OTL78 is an excellent tumor-specific NIR agent for use in fluorescence-guided radical prostatectomy and FGS of other cancers.